These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10777591)

  • 1. Mechanistic studies of the effects of anti-factor H antibodies on complement-mediated lysis.
    Corey MJ; Kinders RJ; Poduje CM; Bruce CL; Rowley H; Brown LG; Hass GM; Vessella RL
    J Biol Chem; 2000 Apr; 275(17):12917-25. PubMed ID: 10777591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement factor H as a marker for detection of bladder cancer.
    Cheng ZZ; Corey MJ; Pärepalo M; Majno S; Hellwage J; Zipfel PF; Kinders RJ; Raitanen M; Meri S; Jokiranta TS
    Clin Chem; 2005 May; 51(5):856-63. PubMed ID: 15774575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of complement-mediated lysis by a peptide derived from SCR 13 of complement factor H.
    Stoiber H; Ammann C; Spruth M; Müllauer B; Eberhart A; Harris CL; Huber CG; Longhi R; Falkensammer B; Würzner R; Dierich MP
    Immunobiology; 2001 May; 203(4):670-86. PubMed ID: 11402501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species specificity of recognition by the alternative pathway of complement.
    Horstmann RD; Pangburn MK; Müller-Eberhard HJ
    J Immunol; 1985 Feb; 134(2):1101-4. PubMed ID: 3155536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
    Schenkman S; Güther ML; Yoshida N
    J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces.
    Ferreira VP; Herbert AP; Hocking HG; Barlow PN; Pangburn MK
    J Immunol; 2006 Nov; 177(9):6308-16. PubMed ID: 17056561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti-factor H antibodies: evidence for multiple interactions between H and surface bound C3b.
    Jokiranta TS; Zipfel PF; Hakulinen J; Kühn S; Pangburn MK; Tamerius JD; Meri S
    FEBS Lett; 1996 Sep; 393(2-3):297-302. PubMed ID: 8814308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
    Koistinen V; Wessberg S; Leikola J
    Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
    Meri S; Pangburn MK
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3982-6. PubMed ID: 1692629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b.
    Ollert MW; David K; Bredehorst R; Vogel CW
    J Immunol; 1995 Nov; 155(10):4955-62. PubMed ID: 7594501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1.
    Junnikkala S; Jokiranta TS; Friese MA; Jarva H; Zipfel PF; Meri S
    J Immunol; 2000 Jun; 164(11):6075-81. PubMed ID: 10820293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
    Ezzell JL; Parker CJ
    Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the alternative pathway of human complement by C1q.
    Fishelson Z; Müller-Eberhard HJ
    Mol Immunol; 1987 Sep; 24(9):987-93. PubMed ID: 2958692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An indirect effect of an antibody on complement deposition and lysis of differently sensitized surrounding cells.
    Bakács T; Lutz HU; Tusnády G; Varga L; Merry AH; Sim RR
    Mol Immunol; 1994 Aug; 31(12):901-11. PubMed ID: 8065373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL; Mikus LK
    J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
    Blom AM; Kask L; Dahlbäck B
    Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway.
    Boackle RJ; Caughman GB; Vesely J; Medgyesi G; Fudenberg HH
    Mol Immunol; 1983 Nov; 20(11):1157-64. PubMed ID: 6228720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
    Johnson E; Eskeland T; Bertheussen K
    Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.